Back to search

Article

Frequent post-treatment monitoring of colorectal cancer using individualized ctDNA validated by multi-regional molecular profiling

2020-06-11

Abstract excerpt

<h4>Purpose</h4> Circulating tumor DNA (ctDNA) analysis has been proposed as an approach for prediction of post-treatment patient outcomes. However, whether a single platform will provide optimal information in all patients or alternatively a patient-specific monitoring approach based on assessment of mutations in the primary tumor from that patient remains an urgent question. Experimental Design: We conducted mul...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2196f84f-cbf2-5603-8339-2893742427e1
DOI
10.1101/2020.06.10.20126367
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Frequent post-treatment monitoring of colorectal cancer using individualized ctDNA validated by multi-regional molecular profilingDOI 10.1101/2020.06.10.20126367
Frequent post-operative monitoring of colorectal cancer using individualised ctDNA validated by multiregional molecular profiling.Semantic proximity
Longitudinal Comparative Analysis of Circulating Tumor DNA and Matched Tumor Tissue DNA in Patients with Metastatic Colorectal Cancer Receiving Palliative First-Line Systemic Anti-Cancer Therapy.Semantic proximity
Prognostic and Predictive Value of Circulating Tumor DNA in Patients with Advanced Colorectal Cancer and ChemotherapySemantic proximity
Proof-of-concept pilot study on comprehensive spatiotemporal intra-patient heterogeneity for colorectal cancer with liver metastasisSemantic proximity
Frequent tumor burden monitoring of esophageal squamous cell carcinoma with circulating tumor DNA using individually designed digital PCRSemantic proximity
Application of Circulating Tumor DNA as a Non-Invasive Tool for Monitoring the Progression of Colorectal Cancer.Semantic proximity
Analysis of the clinical value of postoperative circulating tumor DNA (ctDNA) within the first month for resected colorectal cancer in a real-world.Semantic proximity
Analysis of mutational and proteomic heterogeneity of gastric cancer suggests an effective pipeline to monitor post-treatment tumor burden using circulating tumor DNA.Semantic proximity
Plasma ctDNA enhances the tissue-based detection of oncodriver mutations in colorectal cancerSemantic proximity
Association of Emergence of New Mutations in Circulating Tumuor DNA During Chemotherapy With Clinical Outcome in Metastatic Colorectal CancerSemantic proximity
Patient specific circulating tumor DNA fingerprints to monitor treatment response across multiple tumors.Semantic proximity
Quantitative ctDNA Profiling of RAS Mutations as a Prognostic Biomarker in Metastatic Colorectal CancerSemantic proximity
Select a neighboring publication to make it the new centre.